Mounjaro has shown strong weight loss results in clinical trials and is approved for type 2 diabetes
Makam, A.N., et al., Availability of Cardioprotective Medications for Type 2 Diabetes in the Medicaid Program
If you are ready to build a routine that is tailored to your body's specific needs, we invite you to take the next step
Supplements safety and efficacy can differ among individuals
We're not only lowering the cost of medications, we're also connecting members to real, human care: specialists in obesity and diabetes, clinical pharmacists, and ongoing nutritional support with registered dietitiansall from the comfort of home." Earlier this year, 9amHealth announced the results of a survey that suggests that offering GLP-1 medications through health plans is important for employee retention
The approved-pathway comparison points remain tirzepatide (Mounjaro/Zepbound) on its own and the investigational CagriSema (cagrilintide + semaglutide)